{
    "clinical_study": {
        "@rank": "3047", 
        "arm_group": [
            {
                "arm_group_label": "All patients newly prescribed PPI", 
                "description": "All patients newly prescribed PPI"
            }, 
            {
                "arm_group_label": "All patients newly prescribed H2RA", 
                "description": "All patients newly prescribed H2RA"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is\n\n        1. to estimate the incidence of seizure in the general population  and stratified by\n           epilepsy status\n\n        2. To estimate the  relative risk of seizure associated with use of proton pump inhibitors\n           and histamine 2 receptor antagonist and stratified by epilepsy status"
        }, 
        "brief_title": "Acid Suppressing Drug Seizure Epidemiology Study", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Seizure", 
        "condition_browse": {
            "mesh_term": "Seizures"
        }, 
        "detailed_description": {
            "textblock": "A cohort study with a nested case control analysis on the association between\n      acid-suppressing drugs and seizures using THIN database in the UK"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary care physician for at least 2 years.\n\n          -  Computerized prescription history of at least 1 year.\n\n          -  Patients will have to be free of acid-suppressing drugs (PPI or H2RA) for at least\n             one year.\n\n          -  No diagnosis of cancer.\n\n          -  No alcohol abuse or alcohol-related disease- No drug abuse.\n\n        Exclusion Criteria:\n\n          -  Patients with at least 1 prescription of PPI or H2RA in the year prior to start date.\n\n          -  Cancer before start date.\n\n          -  Alcohol abuse or alcohol-related disease before start date.\n\n          -  Drug abuse before start date."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All individuals aged 20-84 years from 1 January 2005 to 31 December 2011, who have been\n        enrolled with their primary care physician for at least 2 years and have a computerized\n        prescription history of at least 1 year. Patients will have to be free of acid-suppressing\n        drugs (PPI or H2RA) for at least one year, and never have a diagnosis of cancer, alcohol\n        abuse or alcohol-related disease, or drug abuse."
            }
        }, 
        "enrollment": {
            "#text": "534", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744301", 
            "org_study_id": "D9612N00017"
        }, 
        "intervention": {
            "arm_group_label": [
                "All patients newly prescribed PPI", 
                "All patients newly prescribed H2RA"
            ], 
            "description": "Patients newly prescribed PPI and H2RA, respectively", 
            "intervention_name": "Risk of seizure", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Seizure", 
            "Acid-suppressing drugs", 
            "Epidemiology"
        ], 
        "lastchanged_date": "April 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain"
                }, 
                "name": "Research Site"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Cohort Study With a Nested Case Control Analysis on the Association Between Acid-suppressing Drugs and Seizures Using THIN Database in the UK", 
        "overall_official": {
            "affiliation": "CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )", 
            "last_name": "Luis a Garcia Rodriguez, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Product Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of seizure in the general population and stratified by epilepsy status.", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of the study period 1 January 2005-31 December 2011, an expected average of 3 years."
            }, 
            {
                "measure": "Follow-up of safety outcomes:  First recorded entry of seizure.", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of the study period 1 January 2005-31 December 2011, an expected average of 3 years."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744301"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}